What Verified clinical trials does

Verified Clinical Trials (VCT) operates a global, cross-sponsor, cross-therapeutic research subject database registry designed to detect and prevent duplicate enrollment and professional patient activity in clinical trials. The platform performs real-time verification at the screening stage in under 30 seconds, cross-referencing participant records across pharmaceutical sponsors, contract research organizations (CROs), research sites, therapeutic areas, and geographies. The system combines traditional identifiers with optional biometric verification (fingerprint and facial recognition) and supports remote verification for decentralized and virtual clinical trials. VCT holds ISO/IEC 27001 certification, operates across 34-50+ countries through regional support centers in the Americas, Europe, and Asia Pacific, and maintains a wholly-owned China subsidiary (VCT Medical Technology (Shanghai) Co., Ltd.) to handle PRC operations.

The company serves three primary customer segments: pharmaceutical sponsors (100+ unique clients ranging from emerging biotech to the world's largest pharmaceutical corporations), contract research organizations, and clinical research sites/Phase 1 units. Its revenue model is subscription-based, with customized quote-based pricing on multi-year enterprise contracts tailored to sponsor and study requirements. Additional offerings include an ROI Calculator for cost-savings estimation and Site Selection Services for consultative site advisory. In April 2026, VCT announced a strategic alliance with Chubb to integrate its subject registry with clinical trial insurance capabilities, extending into adjacent risk-management services.

VCT was founded in 2009 by Mitchell Efros (Co-Founder and CEO) and Kerri Weingard (Co-Founder and Global COO) and is headquartered in Boca Raton, Florida. The company is privately held with no disclosed institutional funding, operating with a headcount of 11-50 employees. Its primary legal entity is Verified Clinical Trials LLC, with VCT Medical Technology (Shanghai) Co., Ltd. as a wholly-owned regional subsidiary.

Name

Verified clinical trials

Legal name

Verified Clinical Trials LLC

Website

https://verifiedclinicaltrials.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Verified Clinical Trials operates a global, cross-sponsor research subject database registry that detects duplicate enrollment and professional patients in clinical trials, serving 100+ pharmaceutical sponsors, CROs, and research sites across 34-50+ countries via subscription-based enterprise contracts.

Ownership category

akta.pro rank

Product category

Clinical Trial Subject Registry

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

Keywords

• Clinical trial subject registry
• Duplicate subject detection
• Clinical research database
• Biometric verification
• Decentralized clinical trials

Headquarters

HQ city

Garden City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Subscription-Based Subject Registry Access: Verified Clinical Trials provides subscription-based access to its global research subject database registry. Sponsors, CROs, and research sites pay for verification services at screening and throughout study duration. The pricing appears to be volume-based and customized to sponsor and study requirements, with protections continuing from screening through study completion.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Verified Clinical Trials operates a global, cross-sponsor, cross-therapeutic research subject database registry that performs real-time verification of clinical trial participants at the time of screening. The system detects duplicate subjects, professional patients, and protocol violations across sponsors, therapeutic areas, and geographies, using traditional identifiers combined with optional biometric verification (fingerprint and facial recognition). The platform enables compliance and data integrity for Phase 1 through Phase 4 clinical trials.

Product overview

Verified Clinical Trials offers a unified platform centered on its global research subject database and subject registry technology. The core VCT Platform serves as the primary product, enabling real-time verification at screening to detect duplicate subjects, professional research subjects, and protocol violations. This core offering is enhanced by optional Biometrics Verification capabilities (fingerprint and facial recognition) that add accuracy and support remote verification for decentralized trials. The company's DCT Verification module extends functionality to virtual and decentralized trial environments. Additional supporting tools include an ROI Calculator for demonstrating value and Site Selection Services for identifying quality research sites. All components work together within the VCT ecosystem, which spans 50+ countries and serves 100+ sponsors to provide cross-sponsor, cross-therapeutic participant integrity across Phase 1-4 clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Verified Clinical Trials (VCT) Platform The core subject registry and verification platform that detects and prevents duplicate subjects, professional research subjects, and protocol violations in clinical trials at the time of screening. The platform operates as a global, cross-sponsor, cross-therapeutic database spanning 50+ countries, and is targeted at pharmaceutical sponsors, CROs, and research sites.
• Biometrics Verification Optional fingerprint and facial recognition biometric capabilities that enhance subject identification accuracy. Supports remote verification for decentralized and virtual clinical trials. Available to sponsors and sites that require higher-assurance subject identification beyond traditional ID matching.
• VCT Research Subject Database The world's largest and most comprehensive global research subject database, enabling cross-sponsor and cross-therapeutic visibility into participant enrollment history to prevent duplicate enrollment and professional patient activity. Spans 50+ countries with the largest CNS and psychiatry database of any such registry.
• Decentralized Clinical Trials (DCT) Verification Verification capabilities specifically designed for decentralized and virtual clinical trials, enabling remote subject verification through biometric technology. Extends the core platform to DCT environments where participants are not physically present at a research site.
• Site Selection Services Consulting services to help sponsors select higher quality research sites based on subject quality data and historical performance patterns drawn from the VCT database. Provided to pharmaceutical sponsors as an add-on advisory engagement.

Quantifiable outcome

• Duplicate subject detection rate of 4-12% in Phase 2-4 trials, with higher rates in Phase 1 studies
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

One partnership is on record.

• ChubbcoreStrategic or Co-development Partner · 28 April 2026Verified Clinical Trials and Chubb announced a strategic alliance on April 28, 2026, combining VCT's clinical trial subject registry technology with Chubb's global clinical trial insurance capabilities. The partnership integrates VCT's proprietary subject registry—which detects duplicate enrollment and protocol violations—with Chubb's clinical trial insurance and risk management offerings. The alliance provides additive risk mitigation benefits to sponsors, CROs, and research sites, helping them mitigate risks including adverse events, protocol deviations, and compromised data quality associated with duplicate or undisclosed study participation. The collaboration addresses what both companies describe as a longstanding and underrecognized challenge in verifying participant research history.

Scale indicators6 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Mendel Health: Mendel applies an AI-powered clinical knowledge graph to match patients to clinical trials. It is comparable to VCT as both tackle subject-trial matching and clinical trial recruitment integrity, though Mendel emphasizes unstructured EMR-based patient identification rather than cross-sponsor subject registry.
• CluePoints: CluePoints provides risk-based monitoring, centralized statistical monitoring, and data quality analytics for clinical trials. It is comparable because it operates in the clinical trial data-integrity layer adjacent to VCT, addressing protocol deviations and data anomalies that threaten trial outcomes, though it focuses on within-study statistical signals rather than cross-sponsor subject identity.
• Deep 6 AI: Deep 6 AI uses AI to match patients to clinical trials by mining electronic medical record data. It is comparable to VCT because both address subject identification/recruitment integrity in clinical trials, though Deep 6 focuses on patient-to-trial matching within health systems rather than cross-sponsor subject verification.

Emerging players

• Castor: Castor provides an eClinical platform spanning EDC, ePRO, and eConsent with a focus on decentralized trial enablement. It is comparable as an emerging clinical trial data capture platform whose decentralized trial capabilities intersect with VCT's DCT verification product.
• CRIO: CRIO is a clinical trial platform combining eSource, CTMS, and eRegulatory for research sites and sponsors. It is comparable as an emerging player in site/sponsor trial execution software that could expand into subject verification features that overlap with VCT.
• RealTime Software Solutions: RealTime provides CTMS, eRegulatory, and payment solutions for research sites. It is comparable as a site-facing clinical trial platform whose CTMS deployment could either compete with or distribute subject verification services to the research site buyer.

Broad incumbents

• Oracle Health (Clinical One): Oracle's Clinical One platform offers unified EDC, RTSM, and trial supply management for large sponsors. It is comparable as a broad incumbent at the point of trial execution, with existing sponsor integrations where a subject identity/verification feature could conceivably be added.
• Medidata Solutions (Dassault Systèmes): Medidata is the leading EDC/IRT and clinical trial technology platform used by most large sponsors. It is comparable as a broad incumbent whose EDC/IRT systems could plausibly extend into subject verification, and whose existing sponsor relationships could become a competing channel if duplicate detection is bundled in.
• Veeva Systems: Veeva provides CTMS, EDC (Veeva EDC), ePRO, and clinical data management used by large pharma. It is comparable as a broad incumbent clinical trial platform that could integrate or compete with subject registry functionality at the data management layer.
• Clario: Clario delivers eCOA, cardiac safety, medical imaging, and respiratory endpoints, plus broader decentralized trial technology. It is comparable as a broad incumbent in clinical trial technology serving large pharma, with adjacent data integrity and endpoint reliability propositions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/VerifiedTrials
• LinkedInlinkedin.com/company/verified-clinical-trials

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verified clinical trials